Treatment of solid tumors and lymphomas with methyl-CCNU (NSC-95441): a phase II study.
D000328:Adult; D001932:Brain Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D012673:Semustine / Q000009:adverse effects / Q000627:therapeutic use*
D009607:Nitrosourea Compounds; D012673:Semustine